Purchase Order 75D30123P16002

Award Date 2/7/23
Potential Completion Date 8/15/23
Potential Value $46K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chamblee, GA 30341, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Centers for Disease Control and Prevention (CDC) awarded Illumina, Inc. a $160,535.84 firm fixed price purchase order for reagents. The CDC, part of the Department of Health and Human Services, will utilize the reagents in Pittsburgh, Pennsylvania as part of its efforts to advance public health. Illumina will deliver the products from its facilities in San Diego, California by September 30, 2023 to support the CDC's disease prevention and health promotion activities. No set aside designation...
The Centers for Disease Control and Prevention (CDC) awarded a $29,735.58 firm fixed price purchase order to Illumina, Inc. to procure reagents in support of the agency's public health programs. As the prime contractor, Illumina will deliver the requested laboratory supplies to the CDC location in Pittsburgh, Pennsylvania within the two week period of performance from June 30, 2023 through July 13, 2023. No subcontractors or set aside designations were identified. The CDC works domestically...
The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded Illumina, Inc. a $68,541 purchase order to provide LLUMINA MISEQ SYSTEM REAGENTS. The firm fixed price contract has a period of performance from July 3, 2023 through August 19, 2023. Illumina will deliver its Illumina MiSeq System reagents to support the CDC's genomics and sequencing programs. No subcontractors or set aside designations were identified. The contract award utilizes the...
The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $148,290.40 contract is for the provision of lab supplies, with a completion date of September 8, 2021. Illumina has a history of supporting federal agencies like the NIH, CDC, USDA, and VA with its sequencing instruments, reagents, and services....
The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $19,502 purchase order to Illumina, Inc. for ISEQ 100NGS kits. The firm fixed price contract has a period of performance of one day, September 6, 2023. The place of performance will be Illumina's location in Atlanta, Georgia. The CDC is likely procuring the next generation sequencing kits to support genomic surveillance efforts within its broader infectious disease programs. No...
The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded Illumina, Inc. a $116,548 purchase order contract for laboratory equipment. The prime contractor, Illumina, Inc., will deliver the requested equipment to support HHS-CDC programs in San Diego, California by the end-date of August 25, 2023. The firm fixed price contract was awarded on July 11, 2023 to Illumina without a set-aside designation. No major subcontractors or additional context...
This federal contract award to Illumina, Inc. is for the provision of biologicals to the Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh. The $182,360.10 purchase order is a firm fixed price contract with no set-aside designation. Illumina, a manufacturer of goods, has previously provided sequencing systems, reagents, and other products to support genomic analysis for various federal agencies like the NIH, CDC, and VA. This award is not associated...
The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $129,017 purchase order to Illumina, Inc. of Atlanta, Georgia for Illumina laboratory instruments maintenance. The one-year contract, which runs from December 1, 2022 through December 6, 2023, utilizes a firm fixed price structure for maintenance of existing Illumina laboratory equipment in support of CDC's disease prevention and health promotion efforts. No subcontractors or set...
The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $27,274.50 firm fixed price purchase order to Illumina, Inc. of San Diego, California for lab supplies and MiSeq reagent kits. The contract has no set-aside designation and requires completion by October 14, 2022. The MiSeq reagent kits will support the CDC's genomic sequencing work to advance public health goals such as disease surveillance and outbreak response. Illumina will deliver the...
Illumina, Inc. was awarded a $11,922.64 purchase order by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh for unspecified goods or services to be delivered to San Diego, California. The award was made on a firm fixed price basis with no set-aside designation. As a manufacturer and provider of sequencing and array-based solutions, Illumina likely will supply various sequencing systems, reagents, consumables, or related bioinformatics products to...

The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded Illumina, Inc. a $46,172.80 firm fixed price purchase order for Illumina reagents. The place of performance will be Illumina's facility located in Chamblee, Georgia. The period of performance is from February 7, 2023 through August 15, 2023. CDC Pittsburgh is likely procuring the reagents to support its genomic sequencing and bioinformatics programs that help public health agencies detect, track, and respond to infectious disease and environmental health threats. No subcontractors or set aside designations were identified in the award information.

Generated 12/22/23, 10:27 AM